- Home
- PBYI vs LNKB Comparison
PBYI vs LNKB Comparison
Compare PBYI & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- LNKB
- Stock Information
- Founded
- PBYI 2010
- LNKB 2018
- Country
- PBYI United States
- LNKB United States
- Employees
- PBYI N/A
- LNKB N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- PBYI Health Care
- LNKB
- Exchange
- PBYI Nasdaq
- LNKB Nasdaq
- Market Cap
- PBYI 263.4M
- LNKB 261.4M
- IPO Year
- PBYI N/A
- LNKB N/A
- Fundamental
- Price
- PBYI $4.91
- LNKB $7.25
- Analyst Decision
- PBYI Strong Buy
- LNKB Strong Buy
- Analyst Count
- PBYI 1
- LNKB 1
- Target Price
- PBYI $7.00
- LNKB $9.00
- AVG Volume (30 Days)
- PBYI 635.5K
- LNKB 111.7K
- Earning Date
- PBYI 11-06-2025
- LNKB 10-27-2025
- Dividend Yield
- PBYI N/A
- LNKB 4.14%
- EPS Growth
- PBYI 59.87
- LNKB 512.12
- EPS
- PBYI 0.74
- LNKB 1.03
- Revenue
- PBYI $211,995,000.00
- LNKB $122,594,000.00
- Revenue This Year
- PBYI N/A
- LNKB $18.38
- Revenue Next Year
- PBYI N/A
- LNKB N/A
- P/E Ratio
- PBYI $6.61
- LNKB $7.05
- Revenue Growth
- PBYI N/A
- LNKB 42.32
- 52 Week Low
- PBYI $2.32
- LNKB $6.09
- 52 Week High
- PBYI $6.12
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- PBYI 46.97
- LNKB 50.66
- Support Level
- PBYI $4.58
- LNKB $6.97
- Resistance Level
- PBYI $6.12
- LNKB $7.75
- Average True Range (ATR)
- PBYI 0.40
- LNKB 0.20
- MACD
- PBYI -0.05
- LNKB 0.05
- Stochastic Oscillator
- PBYI 20.06
- LNKB 41.28
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.